iShares MSCI ACWI ex U.S. ETF

Shareclass

iShares MSCI ACWI ex US ETF (ACWX)

Type

Exchange-traded fund

Manager

BlackRock/iShares

Military contractors

Largest international arms manufacturers and military contractors

holdings

$243.69M

invested

4.02%

of portfolio

Nuclear weapons

Manufacturers/servicers of nuclear armaments and delivery systems

holdings

$140.61M

invested

2.32%

of portfolio

Controversial weapons

Manufacturers involved with cluster munitions, landmines, white phosphorus, depleted uranium

holdings

$98.41M

invested

1.62%

of portfolio

Military weapon companies

56 holdings

1. Airbus SE
$21.22M
0.35%
2. Safran SA
$20.63M
0.34%
3. Rolls-Royce Holdings PLC
$18.32M
0.3%
4. Rheinmetall AG
$16.04M
0.26%
5. BAE Systems PLC
$14.84M
0.25%

See all

For each weapons category, we show the fund's exposure. When calculating a portfolio's percent exposure to a list of companies, we only consider long investments, ignoring any shorts or liabilities.

Civilian firearm manufacturers and retailers

We also track investments in civilian firearm manufacturers and retailers raking in billions in handgun, assault rifle, and ammunition sales. Gun Free Funds is made for people looking to align their investments with their values by moving money out of companies that make and sell guns.

Gun Free Funds

Visit Gun Free Funds

See the impact of your investments

Regular updates on sustainability risks and ethical concerns in everyday investment products

Sustainability report card

As You Sow’s Invest Your Values report card grades mutual funds on environmental and social issues, including climate change, gender equality, and weapon investments. Click through to get more details on each issue.

iShares MSCI ACWI ex U.S. ETF ACWX

Environment

Fossil fuels

Investments in coal, oil, and natural gas energy and utility companies, and related financial companies

Deforestation

Investments in deforestation-risk agricultural commodities, and related financial companies and consumer brands

Social

Gender equality

Gender equality group ranking, based on Equileap company data

Civilian firearms

Investments in civilian firearms manufacturers, and related gun retailers

Prison industrial complex

Investments in prisons and borders industry, including private prison operators

Military weapons

Investments in military arms manufacturers and services companies, including nuclear weapon manufacturers and servicers

Tobacco

Investments in tobacco and e-cigarette manufacturers, and tobacco-promoting entertainment companies

Search more funds

Financial performance

Performance data provided by

Find more financial data on ACWX at Morningstar.com

Current fund

ACWX

iShares MSCI ACWI ex U.S. ETF

Family

BlackRock/iShares

Category

Foreign Large Blend

Find another fund

vs.

Benchmark

ACWX

iShares MSCI ACWI ex U.S. ETF

Family

iShares from BlackRock

Category

Foreign Large Blend

Change benchmark

Fund comparison settings

Investment timeline

Performance as of: 4/30/25

1 year

3 years

5 years

10 years

Benchmark

Suggested: MSCI ACWI Ex USA

Fund comparison results

Compared to the benchmark, this fund has:

Same

10-yr returns

0% same in annualized returns

Same in military weapons

Same in major military contractors

Same in manufacturers/servicers of nuclear weapons

Same in manufacturers of controversial weapons

Current fund

ACWX

iShares MSCI ACWI ex U.S. ETF

Family

BlackRock/iShares

Category

Foreign Large Blend

Find another fund

vs.

Benchmark

ACWX

iShares MSCI ACWI ex U.S. ETF

Family

iShares from BlackRock

Category

Foreign Large Blend

Change benchmark

Fund comparison settings

Investment timeline

Performance as of: 4/30/25

1 year

3 years

5 years

10 years

Benchmark

Suggested: MSCI ACWI Ex USA

Fund comparison results

Compared to the benchmark, this fund has:

Same

10-yr returns

0% same in annualized returns

Same in military weapons

Same in major military contractors

Same in manufacturers/servicers of nuclear weapons

Same in manufacturers of controversial weapons

Current fund

ACWX

iShares MSCI ACWI ex U.S. ETF

Family

BlackRock/iShares

Category

Foreign Large Blend

Find another fund

vs.

Benchmark

ACWX

iShares MSCI ACWI ex U.S. ETF

Family

iShares from BlackRock

Category

Foreign Large Blend

Change benchmark

Fund comparison settings

Investment timeline

Performance as of: 4/30/25

1 year

3 years

5 years

10 years

Benchmark

Suggested: MSCI ACWI Ex USA

Fund comparison results

Compared to the benchmark, this fund has:

Same

10-yr returns

0% same in annualized returns

Same in military weapons

Same in major military contractors

Same in manufacturers/servicers of nuclear weapons

Same in manufacturers of controversial weapons

Month-end trailing returns

Performance as of date: 4/30/25

Morningstar suggested benchmark: MSCI ACWI Ex USA NR USD

Annualized returns

Climate analysis

1-yr

3-yr

5-yr

10-yr

This fund
ACWX - iShares MSCI ACWI ex U.S. ETF

13%

8.32%

10%

4.72%

4.02%

Benchmark

13%

8.32%

10%

4.72%

4.02%

Fund compared to benchmark

+0%

Same

Find more financial data on ACWX at Morningstar.com

What's next?

Learn how to make a change and move your money

Get started with our action toolkit

Action toolkit

Ask your employer about weapon free options for your retirement plan

Use our toolkit

Find socially responsible funds that are weapon free

Find clean funds

Visit Fossil Free Funds to see exposure to fossil fuels

See climate risk

Disclaimer: As You Sow is not an investment adviser

As You Sow is not an investment adviser as that term is defined under federal and state (California) laws and regulations. As You Sow is a tax-exempt, nonprofit organization dedicated to educating and empowering shareholders to change corporations for the good through the collection, analysis and dissemination of relevant information to the public, free of charge. As You Sow does not provide financial planning, legal or tax advice. Nothing on this website shall constitute or be construed as an offering of financial instruments, or as investment advice or investment recommendations.
See our full disclaimer